VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1800476
Sex: M
Age: 28
State: AZ

Vax Date: 08/03/2021
Onset Date: 08/03/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: BP; Result Unstructured Data: BP Normal.; Test Name: BLOOD TEST; Result Unstructured Data: Blood works normal.; Test Name: ECG; Result Unstructured Data: ECG Normal. Test Name: EKG; Result Unstructured Data: EKG Normal.

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Difficulty of breathing; Anxiety; Problem in sleeping pattern/can't sleep at night time; Chest pain; Feels sick; Numbness; Produces a lot of saliva; Extremely weak; Bulging arm veins; Weird lower back pain (Kidney pain); Experiencing weird dreams; Itchy little bug bites; Itchy little bug bites; Dizziness; On and off extreme fatigue; This spontaneous case was reported by a health care professional and describes the occurrence of DYSPNOEA (Difficulty of breathing), ANXIETY (Anxiety), INSOMNIA (Problem in sleeping pattern/can't sleep at night time), CHEST PAIN (Chest pain) and MALAISE (Feels sick) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066021A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included MAGNESIUM for Stress, PROBIOTICS NOS and ASCORBIC ACID (VIT C) for Supplementation therapy. On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, the patient experienced DYSPNOEA (Difficulty of breathing), ANXIETY (Anxiety), INSOMNIA (Problem in sleeping pattern/can't sleep at night time), CHEST PAIN (Chest pain), MALAISE (Feels sick), HYPOAESTHESIA (Numbness), SALIVARY HYPERSECRETION (Produces a lot of saliva), ASTHENIA (Extremely weak), VASODILATATION (Bulging arm veins), RENAL PAIN (Weird lower back pain (Kidney pain)), ABNORMAL DREAMS (Experiencing weird dreams), ARTHROPOD BITE (Itchy little bug bites), PRURITUS (Itchy little bug bites), DIZZINESS (Dizziness) and FATIGUE (On and off extreme fatigue). The patient was treated with PREDNISOLONE ongoing since an unknown date for Adverse event, at a dose of Took for a month. At the time of the report, DYSPNOEA (Difficulty of breathing), ANXIETY (Anxiety), INSOMNIA (Problem in sleeping pattern/can't sleep at night time), CHEST PAIN (Chest pain), MALAISE (Feels sick), HYPOAESTHESIA (Numbness), SALIVARY HYPERSECRETION (Produces a lot of saliva), ASTHENIA (Extremely weak), VASODILATATION (Bulging arm veins), RENAL PAIN (Weird lower back pain (Kidney pain)), ABNORMAL DREAMS (Experiencing weird dreams), ARTHROPOD BITE (Itchy little bug bites), PRURITUS (Itchy little bug bites), DIZZINESS (Dizziness) and FATIGUE (On and off extreme fatigue) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: normal (normal) BP Normal. On an unknown date, Blood test: normal (normal) Blood works normal. On an unknown date, Electrocardiogram: normal (normal) ECG Normal. and normal (normal) EKG Normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient visited ER three times in a span of 2 months. 1st ER visit was related to difficulty of breathing which was diagnosed as anxiety. he was not getting enough oxygen. At the 2nd ER visit ruled out pulmonary embolism (blood clot in the lungs) and some blood works was done. At the 3rd ER visit ruled out myocarditis.

Other Meds: PROBIOTICS NOS; MAGNESIUM; VIT C.

Current Illness:

ID: 1800477
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: pass 34 days he has been having headaches daily; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (pass 34 days he has been having headaches daily) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (pass 34 days he has been having headaches daily). At the time of the report, HEADACHE (pass 34 days he has been having headaches daily) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication was not reported. Treatment information was not reported.

Other Meds:

Current Illness:

ID: 1800478
Sex: F
Age: 73
State: FL

Vax Date: 01/15/2021
Onset Date: 10/09/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Pillow was soaking wet/swetted it out/Night sweats; left arm was killing me; No energy; Joints hurt; Exhausted; chills; Couldn't eat/no appetite; Very, very ill; Couldn't wake up; Dizzy; Slept for 34 hours; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Couldn't eat/no appetite), ILLNESS (Very, very ill), SOMNOLENCE (Couldn't wake up), DIZZINESS (Dizzy) and SOMNOLENCE (Slept for 34 hours) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039D21A, 013L20A and 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Immunocompromised. Concomitant products included GLIPIZIDE, METFORMIN, SIMVASTATIN, LISINOPRIL and LEVOTHYROXINE for an unknown indication. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Oct-2021, the patient experienced SOMNOLENCE (Slept for 34 hours). On 10-Oct-2021, the patient experienced DECREASED APPETITE (Couldn't eat/no appetite), ILLNESS (Very, very ill), SOMNOLENCE (Couldn't wake up), DIZZINESS (Dizzy), FATIGUE (Exhausted) and CHILLS (chills). On 11-Oct-2021, the patient experienced ASTHENIA (No energy), PAIN IN EXTREMITY (left arm was killing me) and ARTHRALGIA (Joints hurt). On 12-Oct-2021, the patient experienced NIGHT SWEATS (Pillow was soaking wet/swetted it out/Night sweats). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (Couldn't eat/no appetite) had not resolved and ILLNESS (Very, very ill), SOMNOLENCE (Couldn't wake up), DIZZINESS (Dizzy), SOMNOLENCE (Slept for 34 hours), ASTHENIA (No energy), NIGHT SWEATS (Pillow was soaking wet/swetted it out/Night sweats), PAIN IN EXTREMITY (left arm was killing me), FATIGUE (Exhausted), CHILLS (chills) and ARTHRALGIA (Joints hurt) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. This case was linked to MOD-2021-349585 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 14-Oct-2021: Patient decline for the nervousness event.

Other Meds: GLIPIZIDE; METFORMIN; SIMVASTATIN; LISINOPRIL; LEVOTHYROXINE.

Current Illness: Immunocompromised.

ID: 1800479
Sex: F
Age: 73
State: FL

Vax Date: 01/15/2021
Onset Date: 02/28/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: More than 35 days between does 1 and dose 2; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days between does 1 and dose 2) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 013L20A) for COVID-19 vaccination. Concurrent medical conditions included Immunocompromised. Concomitant products included GLIPIZIDE, METFORMIN, SIMVASTATIN, LISINOPRIL and LEVOTHYROXINE for an unknown indication. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days between does 1 and dose 2). On 28-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days between does 1 and dose 2) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Caller reported that she have had the first two doses (Moderna) and experienced no problem. This case was linked to MOD-2021-349550.

Other Meds: GLIPIZIDE; METFORMIN; SIMVASTATIN; LISINOPRIL; LEVOTHYROXINE

Current Illness: Immunocompromised

ID: 1800480
Sex: M
Age:
State:

Vax Date: 02/13/2021
Onset Date: 09/22/2021
Rec V Date: 10/20/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210922; Test Name: positive for covid-19; Test Result: Positive ; Result Unstructured Data: Positive

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: tested positive for covid-19 after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for covid-19 after vaccination) and FEELING ABNORMAL (felt badly) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Sep-2021, the patient experienced COVID-19 (tested positive for covid-19 after vaccination). On an unknown date, the patient experienced FEELING ABNORMAL (felt badly). The patient was treated with MONOCLONAL ANTIBODIES, GRANULOCYTE for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (tested positive for covid-19 after vaccination) outcome was unknown and FEELING ABNORMAL (felt badly) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Sep-2021, SARS-CoV-2 test: positive (Positive) Positive. No concomitant medication were reported.; Sender's Comments: This report concerns a male patient of unknown age with no relevant medical history who experienced a serious unexpected event of COVID-19. The event occurred approximately 7 months after the second dose of mRNA-1273. The report states that patient had a mild disease and was in hospital. The patient was treated with monoclonal antibodies. Re-challenge was not applicable as the event happened after the second dose, and no additional dosing will be given. There is no information about the first dose. Outcome of the event COVID-19 was unknown. The benefit-risk relationship of mRNA-1273 is not affected by this report.

Other Meds:

Current Illness:

ID: 1800481
Sex: U
Age:
State:

Vax Date: 05/01/2021
Onset Date:
Rec V Date: 10/20/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: (Arm) had a pretty big bruise (at injection site) for 5 to 6 weeks; Arm was red (at injection site) for 5 to 6 weeks; I decided not to get second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING ((Arm) had a pretty big bruise (at injection site) for 5 to 6 weeks), VACCINATION SITE ERYTHEMA (Arm was red (at injection site) for 5 to 6 weeks) and PRODUCT DOSE OMISSION ISSUE (I decided not to get second dose) in a 52-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE BRUISING ((Arm) had a pretty big bruise (at injection site) for 5 to 6 weeks), VACCINATION SITE ERYTHEMA (Arm was red (at injection site) for 5 to 6 weeks) and PRODUCT DOSE OMISSION ISSUE (I decided not to get second dose). At the time of the report, VACCINATION SITE BRUISING ((Arm) had a pretty big bruise (at injection site) for 5 to 6 weeks), VACCINATION SITE ERYTHEMA (Arm was red (at injection site) for 5 to 6 weeks) and PRODUCT DOSE OMISSION ISSUE (I decided not to get second dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The concomitant history was not reported. The treatment history was not provided.

Other Meds:

Current Illness:

ID: 1800482
Sex: M
Age: 72
State: TX

Vax Date: 01/04/2021
Onset Date:
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body temperature; Result Unstructured Data: 101 fever

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: He starts to get sick in the middle afternoon; Migraine; chills and fever on and off has happened 4 times in total by 7 pm he has fever 101 fever all night; 3 pm starts chills by 5 pm he has chills; headache this morning; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (He starts to get sick in the middle afternoon), MIGRAINE (Migraine), PYREXIA (chills and fever on and off has happened 4 times in total by 7 pm he has fever 101 fever all night), CHILLS (3 pm starts chills by 5 pm he has chills) and HEADACHE (headache this morning) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A, 041LC0A and 045C21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Flu shot. Past adverse reactions to the above products included Adverse event with Flu shot. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (He starts to get sick in the middle afternoon), MIGRAINE (Migraine), PYREXIA (chills and fever on and off has happened 4 times in total by 7 pm he has fever 101 fever all night), CHILLS (3 pm starts chills by 5 pm he has chills) and HEADACHE (headache this morning). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] (oral) for Migraine, at an unspecified dose and frequency. At the time of the report, ILLNESS (He starts to get sick in the middle afternoon), MIGRAINE (Migraine), PYREXIA (chills and fever on and off has happened 4 times in total by 7 pm he has fever 101 fever all night), CHILLS (3 pm starts chills by 5 pm he has chills) and HEADACHE (headache this morning) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101 fever. No concomitant medications were reported. Patient had no actual side effects from the vaccines themselves and reported he took lots of medications daily but unspecified and stated he took the 3rd dose and he mentioned he wasn't supposed to.

Other Meds:

Current Illness:

ID: 1800483
Sex: F
Age: 68
State: NJ

Vax Date: 03/01/2021
Onset Date: 09/13/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Antibody test; Test Result: Negative ; Result Unstructured Data: Antibody test negative.

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: there was general malaise; feeling a little sick; fever with booster; sore arm; pain in arm; I did get a headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (there was general malaise), MALAISE (feeling a little sick), PAIN IN EXTREMITY (pain in arm), HEADACHE (I did get a headache) and PYREXIA (fever with booster) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Lymphoma (The patient had a history of lymphoma for which she is on a maintenance infusion.). Concomitant products included PRAVASTATIN, PANTOPRAZOLE, DEXAMETHASONE, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), PARACETAMOL (TYLENOL), RITUXIMAB (TRUXIMA [RITUXIMAB]), COLECALCIFEROL (VITAMIN D3), CALCIUM, ACETYLSALICYLIC ACID (ASPIRIN), MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE] and ONDANSETRON for an unknown indication. In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Sep-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), HEADACHE (I did get a headache) and MYALGIA (sore arm). On 14-Sep-2021, the patient experienced MALAISE (there was general malaise), MALAISE (feeling a little sick) and PYREXIA (fever with booster). The patient was treated with PEDIALYTE FREEZER POPS [ASPARTAME;CARMELLOSE;CITRIC ACID;FRUCTOSE;GLUCOSE;POTASSIUM CHLORIDE;POTASSIUM SORBATE;SODIUM BENZOATE;SODIUM CITRATE] for Adverse event, at an unspecified dose and frequency. On 15-Sep-2021, MALAISE (there was general malaise), MALAISE (feeling a little sick), HEADACHE (I did get a headache), PYREXIA (fever with booster) and MYALGIA (sore arm) had resolved. At the time of the report, PAIN IN EXTREMITY (pain in arm) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: negative (Negative) Antibody test negative.. The patient was also taking Cagament and Hygil concomitantly. The patient was again tested for antibodies after receiving the 3rd dose, which was also negative. The patient didn't had side effects from the first two doses. The patient experienced a fever, headache, and sore arm after receiving the 3rd dose. She said that the pain in the arm and headache started the same evening of the shot. The feeling of general malaise, fever, and feeling sick started the following day. The headache lasted for 1 - 1.5 days and the sore arm lasted for a couple of days. All other symptoms only lasted for a day after which she felt fine.

Other Meds: PRAVASTATIN; PANTOPRAZOLE; DEXAMETHASONE; BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]; TYLENOL; TRUXIMA [RITUXIMAB]; VITAMIN D3; CALCIUM; ASPIRIN; MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID

Current Illness:

ID: 1800484
Sex: M
Age: 63
State: AZ

Vax Date: 02/10/2021
Onset Date: 10/12/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: expired dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 011A21A) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not provided by the reporter. Treatment medication was not given. This case was linked to MOD-2021-350559 (Patient Link).

Other Meds:

Current Illness:

ID: 1800485
Sex: F
Age: 72
State: FL

Vax Date: 10/04/2021
Onset Date: 10/04/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Left arm was sore at the injection site; She has a rash around the area she received injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left arm was sore at the injection site) and VACCINATION SITE RASH (She has a rash around the area she received injection) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. No Medical History information was reported. On 04-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Oct-2021, the patient experienced VACCINATION SITE PAIN (Left arm was sore at the injection site) and VACCINATION SITE RASH (She has a rash around the area she received injection). At the time of the report, VACCINATION SITE PAIN (Left arm was sore at the injection site) and VACCINATION SITE RASH (She has a rash around the area she received injection) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment medications were not provided by the reporter. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1800486
Sex: F
Age: 69
State: OK

Vax Date: 01/10/2021
Onset Date:
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Strong reaction; Felt like a "kick in the pants"; Body aches; Fever for 5 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Strong reaction), FEELING ABNORMAL (Felt like a "kick in the pants"), MYALGIA (Body aches) and PYREXIA (Fever for 5 days) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. Concurrent medical conditions included Lymphedema. On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Strong reaction), FEELING ABNORMAL (Felt like a "kick in the pants"), MYALGIA (Body aches) and PYREXIA (Fever for 5 days). At the time of the report, VACCINATION COMPLICATION (Strong reaction), FEELING ABNORMAL (Felt like a "kick in the pants"), MYALGIA (Body aches) and PYREXIA (Fever for 5 days) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication information was not provided by the reporter. Treatment information was not provided by the reporter. This case was linked to MOD-2021-350345 (Patient Link).

Other Meds:

Current Illness: Lymphedema

ID: 1800487
Sex: F
Age: 59
State: CA

Vax Date: 07/27/2021
Onset Date:
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Muscle spasms in the legs; Achy sore weakness that is dreadful, not comfortable and agonizing / achiness is all over the body; Jaw is hurting; Has jaw issues; Haven't had much of an appetite; Is generally feeling unwell; Achy sore weakness that is dreadful, not comfortable and agonizing / achiness is all over the body; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Muscle spasms in the legs), MUSCULAR WEAKNESS (Achy sore weakness that is dreadful, not comfortable and agonizing / achiness is all over the body), PAIN IN JAW (Jaw is hurting), JAW DISORDER (Has jaw issues) and DECREASED APPETITE (Haven't had much of an appetite) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (ZUBSOLV) for an unknown indication. On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Muscle spasms in the legs), MUSCULAR WEAKNESS (Achy sore weakness that is dreadful, not comfortable and agonizing / achiness is all over the body), PAIN IN JAW (Jaw is hurting), JAW DISORDER (Has jaw issues), DECREASED APPETITE (Haven't had much of an appetite), VACCINATION COMPLICATION (Is generally feeling unwell) and MYALGIA (Achy sore weakness that is dreadful, not comfortable and agonizing / achiness is all over the body). At the time of the report, MUSCLE SPASMS (Muscle spasms in the legs), MUSCULAR WEAKNESS (Achy sore weakness that is dreadful, not comfortable and agonizing / achiness is all over the body), PAIN IN JAW (Jaw is hurting), JAW DISORDER (Has jaw issues), DECREASED APPETITE (Haven't had much of an appetite), VACCINATION COMPLICATION (Is generally feeling unwell) and MYALGIA (Achy sore weakness that is dreadful, not comfortable and agonizing / achiness is all over the body) outcome was unknown. No treatment information was provided. This case was linked to MOD-2021-350356 (Patient Link).

Other Meds: ZUBSOLV

Current Illness:

ID: 1800488
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Headache; injection site was sufficiently sore; head to toe body aches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), VACCINATION SITE PAIN (injection site was sufficiently sore) and MYALGIA (head to toe body aches) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Diabetes. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), VACCINATION SITE PAIN (injection site was sufficiently sore) and MYALGIA (head to toe body aches). At the time of the report, HEADACHE (Headache), VACCINATION SITE PAIN (injection site was sufficiently sore) and MYALGIA (head to toe body aches) had resolved. Not Provided No concomitant medication was provided Treatment medication was not provided by the reporter Reporter was informed by my father on 10Oct2021 that a close family friend received a Moderna Covid-19 booster (third shot) from his local health department. The patient (SW, male) is likely in his 70s and it had been >8months since his second shot. Patient had more severe side effects than the second shot. He got the shot Thursday am and had a headache by 10 pm. The injection site was sufficiently sore to avoid all contact and he had head to toe body aches all through the night. Symptoms reduced by Friday am and were completely gone by Friday evening. This case was linked to MOD-2021-350359 (Patient Link).

Other Meds:

Current Illness: Diabetes

ID: 1800489
Sex: F
Age: 75
State: FL

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: sore arm after first dose; extremely tired after taking 1st dose; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm after first dose) and FATIGUE (extremely tired after taking 1st dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K2DA) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm after first dose) and FATIGUE (extremely tired after taking 1st dose). On 05-Feb-2021, PAIN IN EXTREMITY (sore arm after first dose) and FATIGUE (extremely tired after taking 1st dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient received the vaccine at Pharmacy concomitant medications reported were OTC vitamins treatment included good sleep and hot water bottle to sore arm were taken This case was linked to MOD-2021-350385, MOD-2021-350398 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 12-Oct-2021: Follow up received, contains non significant information.

Other Meds:

Current Illness:

ID: 1800490
Sex: F
Age: 59
State: CA

Vax Date: 07/27/2021
Onset Date:
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Bitten by a dog; This spontaneous case was reported by a consumer and describes the occurrence of ANIMAL BITE (Bitten by a dog) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (ZUBSOLV) for an unknown indication. On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ANIMAL BITE (Bitten by a dog). The patient was treated with TETANUS VACCINE at a dose of booster. At the time of the report, ANIMAL BITE (Bitten by a dog) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information included series of antibiotics and tetanus booster. This case was linked to MOD-2021-350320 (Patient Link).

Other Meds: ZUBSOLV

Current Illness:

ID: 1800491
Sex: F
Age: 29
State: NY

Vax Date: 10/12/2021
Onset Date: 10/12/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Vaccine administered from a vial greater than 12 hours post-puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered from a vial greater than 12 hours post-puncture) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 061E21A) for COVID-19 vaccination. Concomitant products included ETHINYLESTRADIOL, NORGESTIMATE (SPRINTEC) for Birth control. On 12-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Oct-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered from a vial greater than 12 hours post-puncture). On 12-Oct-2021, PRODUCT STORAGE ERROR (Vaccine administered from a vial greater than 12 hours post-puncture) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided.

Other Meds: SPRINTEC

Current Illness:

ID: 1800492
Sex: F
Age: 67
State: NV

Vax Date: 01/25/2021
Onset Date: 09/23/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: pain in the whole body; fever; fatigue; got the 3rd dose thinking it was the booster for her age, because she is not immunocompromised; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (pain in the whole body), PYREXIA (fever), FATIGUE (fatigue) and OFF LABEL USE (got the 3rd dose thinking it was the booster for her age, because she is not immunocompromised) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 061E21A, 023M20A and 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Sep-2021, the patient experienced MYALGIA (pain in the whole body), PYREXIA (fever), FATIGUE (fatigue) and OFF LABEL USE (got the 3rd dose thinking it was the booster for her age, because she is not immunocompromised). On 23-Sep-2021, OFF LABEL USE (got the 3rd dose thinking it was the booster for her age, because she is not immunocompromised) had resolved. At the time of the report, MYALGIA (pain in the whole body), PYREXIA (fever) and FATIGUE (fatigue) was resolving. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant medications were provided by the reporter. No Treatment Information was provided by the reporter. This case was linked to MOD-2021-350396 (Patient Link).

Other Meds:

Current Illness:

ID: 1800493
Sex: F
Age: 81
State: AL

Vax Date: 10/09/2021
Onset Date: 10/09/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Severe itching on her left arm at injection site down to her elbow 24 hours a day. It had gotten worse.; Redness on her left arm at injection site down to her elbow 24 hours a day. It had gotten worse.; 2nd dose-25 Feb 2021 and 3rd dose-09 oct 2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose-25 Feb 2021 and 3rd dose-09 oct 2021), VACCINATION SITE PRURITUS (Severe itching on her left arm at injection site down to her elbow 24 hours a day. It had gotten worse.) and VACCINATION SITE ERYTHEMA (Redness on her left arm at injection site down to her elbow 24 hours a day. It had gotten worse.) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062E21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose-25 Feb 2021 and 3rd dose-09 oct 2021). On 10-Oct-2021, the patient experienced VACCINATION SITE PRURITUS (Severe itching on her left arm at injection site down to her elbow 24 hours a day. It had gotten worse.) and VACCINATION SITE ERYTHEMA (Redness on her left arm at injection site down to her elbow 24 hours a day. It had gotten worse.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form; AVENA SATIVA FLUID EXTRACT at a dose of 1 dosage form and CORTISONE at a dose of 1 dosage form. On 09-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose-25 Feb 2021 and 3rd dose-09 oct 2021) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Severe itching on her left arm at injection site down to her elbow 24 hours a day. It had gotten worse.) and VACCINATION SITE ERYTHEMA (Redness on her left arm at injection site down to her elbow 24 hours a day. It had gotten worse.) outcome was unknown. No concomitant medication was provided. Treatment medication include Non-drugs treatment Icepacks This case was linked to MOD-2021-350376, MOD-2021-350425 .

Other Meds:

Current Illness:

ID: 1800494
Sex: F
Age: 89
State: NM

Vax Date: 01/22/2021
Onset Date: 02/27/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: I could hardly stand; my body didn't feel right; legs were wobbly; head was achy; This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (I could hardly stand), VACCINATION COMPLICATION (my body didn't feel right), MUSCULAR WEAKNESS (legs were wobbly) and HEADACHE (head was achy) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced DYSSTASIA (I could hardly stand), VACCINATION COMPLICATION (my body didn't feel right), MUSCULAR WEAKNESS (legs were wobbly) and HEADACHE (head was achy). On 28-Feb-2021, DYSSTASIA (I could hardly stand), VACCINATION COMPLICATION (my body didn't feel right), MUSCULAR WEAKNESS (legs were wobbly) and HEADACHE (head was achy) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications included vitamins, minerals and eye drops. Patient reported losing her hair and eyesight. However, she said all that has been happening since before receiving the vaccine, and due to her old age.

Other Meds:

Current Illness:

ID: 1800495
Sex: F
Age: 78
State: NJ

Vax Date: 10/09/2021
Onset Date: 10/12/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The patient's past medical history included Mitral valve prolapse. Concurrent medical conditions included Blood pressure high. On 09-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Oct-2021, the patient experienced DIZZINESS (Dizzy). At the time of the report, DIZZINESS (Dizzy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The concomitant medication used were Beta Blocker For HBP and another medicine for Mitral valve prolapse No treatment details were reported.

Other Meds:

Current Illness: Blood pressure high

ID: 1800496
Sex: M
Age: 18
State: NC

Vax Date: 09/09/2021
Onset Date: 10/12/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Had received their second dose of the Moderna covid-19 vaccine after the dose had passed the published expiration date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Had received their second dose of the Moderna covid-19 vaccine after the dose had passed the published expiration date) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049E21A and 051C21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Oct-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Had received their second dose of the Moderna covid-19 vaccine after the dose had passed the published expiration date). On 12-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Had received their second dose of the Moderna covid-19 vaccine after the dose had passed the published expiration date) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not reported. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds:

Current Illness:

ID: 1800497
Sex: M
Age: 44
State: NC

Vax Date: 09/09/2021
Onset Date: 10/12/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: 12 hours out of expiration; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (12 hours out of expiration) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051C21A and 049E21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (12 hours out of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (12 hours out of expiration) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication information was not provided by the reporter. Treatment information was not provided by the reporter. This case was linked to MOD-2021-350532 (Patient Link).

Other Meds:

Current Illness:

ID: 1800498
Sex: M
Age: 68
State: AZ

Vax Date: 01/06/2021
Onset Date: 10/12/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: expired dose; Inappropriate schedule of vaccine administered/ He received his second dose on 03-Feb-2021 and third dose on 12-Oct-2021; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered/ He received his second dose on 03-Feb-2021 and third dose on 12-Oct-2021) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A, 013M20A and 039K20A) for COVID-19 vaccination. Concurrent medical conditions included Immunocompromised. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered/ He received his second dose on 03-Feb-2021 and third dose on 12-Oct-2021). On 12-Oct-2021, EXPIRED PRODUCT ADMINISTERED (expired dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered/ He received his second dose on 03-Feb-2021 and third dose on 12-Oct-2021) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. This case was linked to MOD-2021-350294, MOD-2021-350297, MOD-2021-350305, MOD-2021-350432, MOD-2021-350584 (Patient Link).

Other Meds:

Current Illness: Immunocompromised

ID: 1800499
Sex: F
Age: 50
State: WI

Vax Date: 10/08/2021
Onset Date: 10/08/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: hot flashes; body aches,; nausea at work; little bit of chills (no fever); stomach ache; she had an in and out headache; felt half decent,; she felt dizzy; her arm hurt a little bit; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (felt half decent,), DIZZINESS (she felt dizzy), PAIN IN EXTREMITY (her arm hurt a little bit), HOT FLUSH (hot flashes) and ABDOMINAL PAIN UPPER (stomach ache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included FLUOXETINE, PANTOPRAZOLE and IBUPROFEN for an unknown indication. On 08-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Oct-2021, the patient experienced VACCINATION COMPLICATION (felt half decent,), DIZZINESS (she felt dizzy) and PAIN IN EXTREMITY (her arm hurt a little bit). On 10-Oct-2021, the patient experienced HEADACHE (she had an in and out headache). On 11-Oct-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), NAUSEA (nausea at work) and CHILLS (little bit of chills (no fever)). On 12-Oct-2021, the patient experienced HOT FLUSH (hot flashes) and MYALGIA (body aches,). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (felt half decent,), DIZZINESS (she felt dizzy), PAIN IN EXTREMITY (her arm hurt a little bit), HOT FLUSH (hot flashes), ABDOMINAL PAIN UPPER (stomach ache), HEADACHE (she had an in and out headache), NAUSEA (nausea at work), CHILLS (little bit of chills (no fever)) and MYALGIA (body aches,) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: FLUOXETINE; PANTOPRAZOLE; IBUPROFEN.

Current Illness:

ID: 1800500
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: liver biopsy; Result Unstructured Data: Fatty liver; Test Date: 20210728; Test Name: Glycosylated haemoglobin; Result Unstructured Data: 6

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: makes a little bump like somthing stung her but it didnt and breakout in hives; fatty liver; itching of legs ,hand and feet; dryness in the back of her throat; feels bad; feeling like something is stinging her; recently developed a reaction to eating seafood and plaine fish; makes mark thats stay on her and they fade but dont ever go away on her legs and stomach; didn't have her vascepa for two r three days and woke up with a rash; she was struck in an airport and didn't have their vascepa for two or three days; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (makes a little bump like somthing stung her but it didnt and breakout in hives), HEPATIC STEATOSIS (fatty liver), PRURITUS (itching of legs ,hand and feet), DRY THROAT (dryness in the back of her throat) and FEELING ABNORMAL (feels bad) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Co-suspect product included non-company product EICOSAPENTAENOIC ACID ETHYL ESTER (VASCEPA) for Blood cholesterol increased. The patient's past medical history included Abortion spontaneous in 1991. Concurrent medical conditions included Basedow's disease since 1996, Thyroidectomy since 1996, Type 2 diabetes mellitus since 2011, Abstains from alcohol, Hernia hiatus repair and Rhesus antigen negative. Concomitant products included PIOGLITAZONE, GABAPENTIN, AMLODIPINE BESILATE, BENAZEPRIL HYDROCHLORIDE (AMLODIPINE/BENAZEPRIL), ROSUVASTATIN, LEVOTHYROXINE and MELOXICAM for an unknown indication. In 2015, the patient started EICOSAPENTAENOIC ACID ETHYL ESTER (VASCEPA) (Oral) 2 dosage form twice a day. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (makes a little bump like somthing stung her but it didnt and breakout in hives), HEPATIC STEATOSIS (fatty liver), PRURITUS (itching of legs ,hand and feet), DRY THROAT (dryness in the back of her throat), FEELING ABNORMAL (feels bad), PAIN OF SKIN (feeling like something is stinging her), FOOD ALLERGY (recently developed a reaction to eating seafood and plaine fish), RASH (makes mark thats stay on her and they fade but dont ever go away on her legs and stomach), RASH (didn't have her vascepa for two r three days and woke up with a rash) and THERAPY INTERRUPTED (she was struck in an airport and didn't have their vascepa for two or three days). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE (BENADRYL ITCH RELIEF) for Adverse event, at an unspecified dose and frequency. At the time of the report, URTICARIA (makes a little bump like somthing stung her but it didnt and breakout in hives), HEPATIC STEATOSIS (fatty liver), PRURITUS (itching of legs ,hand and feet), DRY THROAT (dryness in the back of her throat), FEELING ABNORMAL (feels bad), PAIN OF SKIN (feeling like something is stinging her) and FOOD ALLERGY (recently developed a reaction to eating seafood and plaine fish) outcome was unknown, RASH (makes mark thats stay on her and they fade but dont ever go away on her legs and stomach) had not resolved and RASH (didn't have her vascepa for two r three days and woke up with a rash) and THERAPY INTERRUPTED (she was struck in an airport and didn't have their vascepa for two or three days) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jul-2021, Haemoglobin: 6 (Low) 6. On an unknown date, Biopsy liver: abnormal (abnormal) Fatty liver. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient medical history includes graves disease and non tobacco user. The patient had undergone liver biopsy at the end of 2019 and early's of 2020

Other Meds: PIOGLITAZONE; GABAPENTIN; AMLODIPINE/BENAZEPRIL; ROSUVASTATIN; LEVOTHYROXINE; MELOXICAM.

Current Illness: Abstains from alcohol; Basedow's disease; Hernia hiatus repair; Rhesus antigen negative; Thyroidectomy; Type 2 diabetes mellitus.

ID: 1800501
Sex: F
Age: 48
State: TX

Vax Date: 07/07/2021
Onset Date:
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Even more confused; Very drowzy,patient is falling asleep while driving; Patient is having trouble with driving; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Even more confused), SOMNOLENCE (Very drowzy,patient is falling asleep while driving) and IMPAIRED DRIVING ABILITY (Patient is having trouble with driving) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication. On 07-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In August 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CONFUSIONAL STATE (Even more confused), SOMNOLENCE (Very drowzy,patient is falling asleep while driving) and IMPAIRED DRIVING ABILITY (Patient is having trouble with driving). At the time of the report, CONFUSIONAL STATE (Even more confused), SOMNOLENCE (Very drowsy, patient is falling asleep while driving) and IMPAIRED DRIVING ABILITY (Patient is having trouble with driving) outcome was unknown. No treatment medication was reported. This case was linked to MOD-2021-340945 (Patient Link).

Other Meds: TYLENOL

Current Illness:

ID: 1800502
Sex: U
Age:
State:

Vax Date: 10/07/2021
Onset Date: 10/07/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: developed a severe adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (developed a severe adverse reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 07-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Oct-2021, the patient experienced VACCINATION COMPLICATION (developed a severe adverse reaction). At the time of the report, VACCINATION COMPLICATION (developed a severe adverse reaction) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported. No treatment medication was reported. On October 07 2021, Patient received the first shot of the Moderna COVID-19 vaccination series. After 10 to 15 minutes, patient developed a severe adverse reaction and was transferred to the Emergency department via ambulance.

Other Meds:

Current Illness:

ID: 1800503
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: burning sensation in his arm and shooting up his neck; This spontaneous case was reported by a pharmacist and describes the occurrence of BURNING SENSATION (burning sensation in his arm and shooting up his neck) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (burning sensation in his arm and shooting up his neck). At the time of the report, BURNING SENSATION (burning sensation in his arm and shooting up his neck) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1800504
Sex: F
Age: 78
State: MN

Vax Date: 10/12/2021
Onset Date: 10/12/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Patient was administered an expired dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired dose of the Moderna COVID-19 vaccine) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination. No Medical History Information was reported. Concomitant products included AMLODIPINE, ATORVASTATIN, BACLOFEN, CITALOPRAM, CLONAZEPAM, MAGNESIUM, PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE (MIRAPEX), LOPERAMIDE HYDROCHLORIDE (IMODIUM) and VITAMIN D NOS for an unknown indication. On 12-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired dose of the Moderna COVID-19 vaccine). On 12-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired dose of the Moderna COVID-19 vaccine) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment medications were reported. Symptoms: The patient did not experienced any symptoms, The medical assistant confirmed that only one patient received expired dose and the vial was initially stored in the refrigerator on 13-Sep-2021 and it did not went under any temperature excursions.

Other Meds: AMLODIPINE; ATORVASTATIN; BACLOFEN; CITALOPRAM; CLONAZEPAM; MAGNESIUM; MIRAPEX; IMODIUM; VITAMIN D NOS

Current Illness:

ID: 1800505
Sex: F
Age: 48
State: LA

Vax Date: 02/25/2021
Onset Date: 09/01/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: I never felt this bad in my entire life; I missed 3 weeks of work/not being able to function; My left arm was tensed up.; I have depression from not being able to function; pain everywhere; Whole left side of body from middle of chest down to arm felt pain and tense; Arm felt pain; muscle pain/muscle aches; I'm having breathing problems/I can't catch my breath; difficulty walking/I can't walk from one room to the next; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (I'm having breathing problems/I can't catch my breath), FEELING ABNORMAL (I never felt this bad in my entire life), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I missed 3 weeks of work/not being able to function), LIMB DISCOMFORT (My left arm was tensed up.) and DEPRESSION (I have depression from not being able to function) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A, 012A21A and 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In September 2021, the patient experienced DYSPNOEA (I'm having breathing problems/I can't catch my breath), GAIT DISTURBANCE (difficulty walking/I can't walk from one room to the next) and MYALGIA (muscle pain/muscle aches). On an unknown date, the patient experienced FEELING ABNORMAL (I never felt this bad in my entire life), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I missed 3 weeks of work/not being able to function), LIMB DISCOMFORT (My left arm was tensed up.), DEPRESSION (I have depression from not being able to function), PAIN (pain everywhere), CHEST PAIN (Whole left side of body from middle of chest down to arm felt pain and tense) and PAIN IN EXTREMITY (Arm felt pain). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency; ALBUTEROL [SALBUTAMOL] for Adverse event, at an unspecified dose and frequency; DOXYCYCLINE for Adverse event, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; LEVOFLOXACIN (LEVAQUIN) for Adverse event, at an unspecified dose and frequency and FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY) for Adverse event, at an unspecified dose and frequency. At the time of the report, DYSPNOEA (I'm having breathing problems/I can't catch my breath), GAIT DISTURBANCE (difficulty walking/I can't walk from one room to the next) and MYALGIA (muscle pain/muscle aches) had not resolved and FEELING ABNORMAL (I never felt this bad in my entire life), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I missed 3 weeks of work/not being able to function), LIMB DISCOMFORT (My left arm was tensed up.), DEPRESSION (I have depression from not being able to function), PAIN (pain everywhere), CHEST PAIN (Whole left side of body from middle of chest down to arm felt pain and tense) and PAIN IN EXTREMITY (Arm felt pain) outcome was unknown.

Other Meds: SYNTHROID

Current Illness:

ID: 1800506
Sex: F
Age: 82
State: GA

Vax Date: 10/12/2021
Onset Date: 10/12/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: doses administered past the published expiry date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date). On 12-Oct-2021, EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1800507
Sex: F
Age: 99
State: GA

Vax Date: 10/12/2021
Onset Date: 10/12/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: doses administered past the published expiry date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date) in a 99-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date). On 12-Oct-2021, EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant drug details were reported. No treatment details were reported.

Other Meds:

Current Illness:

ID: 1800508
Sex: M
Age: 72
State: GA

Vax Date: 09/09/2021
Onset Date: 09/09/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date.) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date.). On 09-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date.) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Treatment information was unknown. It was reported that the vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration. The vials did not undergo any temperature excursions.

Other Meds:

Current Illness:

ID: 1800509
Sex: F
Age: 75
State: GA

Vax Date: 09/09/2021
Onset Date: 09/09/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Moderna COVID-19 vaccine was administered to patients past the published expiry date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date). On 09-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications reported. No treatment reported. The vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration. The vials did not undergo any temperature excursions

Other Meds:

Current Illness:

ID: 1800510
Sex: U
Age:
State: ND

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Administered expired vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine). On 22-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant information was not provided. Treatment information was not provided

Other Meds:

Current Illness:

ID: 1800511
Sex: M
Age: 98
State: GA

Vax Date: 09/09/2021
Onset Date: 09/09/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Moderna COVID-19 vaccine was administered to patients past the published expiry date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date) in a 98-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date). On 09-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided. No treatment information was provided. The vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration. The vials did not undergo any temperature excursions

Other Meds:

Current Illness:

ID: 1800512
Sex: M
Age: 83
State: GA

Vax Date: 09/09/2021
Onset Date: 09/09/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Moderna COVID-19 vaccine was administered to patients past the published expiry date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date). On 09-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration. The vials did not undergo any temperature excursions Concomitant medication use was unknown Treatment information was unknown

Other Meds:

Current Illness:

ID: 1800513
Sex: F
Age: 83
State: GA

Vax Date: 09/16/2021
Onset Date: 09/16/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). On 16-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not provided. Treatment information was not provided. The vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration. The vials did not undergo any temperature excursions

Other Meds:

Current Illness:

ID: 1800514
Sex: M
Age: 83
State: GA

Vax Date: 09/16/2021
Onset Date: 09/16/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). On 16-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was mentioned. No treatment medication was mentioned.

Other Meds:

Current Illness:

ID: 1800515
Sex: F
Age: 81
State: GA

Vax Date: 09/16/2021
Onset Date: 09/16/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). On 16-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. The vials were stored in the freezer and taken out of the freezer and placed on the date of administration. The vials did not undergo any temperature excursions. No treatment medications were provided.

Other Meds:

Current Illness:

ID: 1800516
Sex: F
Age: 79
State: GA

Vax Date: 09/16/2021
Onset Date: 09/16/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry). On 16-Sep-2021, EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant and treatment medications are provided by the reporter. The vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration. The vials did not undergo any temperature excursions.

Other Meds:

Current Illness:

ID: 1800517
Sex: F
Age: 48
State: CA

Vax Date: 03/29/2021
Onset Date:
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: I have been having two weeks of persistent abnormal bleeding, This abnormal bleeding began September 14, stopped after 3 days then began again; itchiness; I skipped a cycle in August; Clotty kind of blood, which is abnormal than my regular period; I had fever after both shots, 102 degrees fahrenheit at first dose, and 101fahrenheit after second dose; I had chills; muscle ache; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUAL DISORDER (I have been having two weeks of persistent abnormal bleeding, This abnormal bleeding began September 14, stopped after 3 days then began again), PRURITUS (itchiness), MENSTRUATION DELAYED (I skipped a cycle in August), INTERMENSTRUAL BLEEDING (Clotty kind of blood, which is abnormal than my regular period) and PYREXIA (I had fever after both shots, 102 degrees fahrenheit at first dose, and 101fahrenheit after second dose) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MENSTRUAL DISORDER (I have been having two weeks of persistent abnormal bleeding, This abnormal bleeding began September 14, stopped after 3 days then began again), PRURITUS (itchiness), MENSTRUATION DELAYED (I skipped a cycle in August), INTERMENSTRUAL BLEEDING (Clotty kind of blood, which is abnormal than my regular period), PYREXIA (I had fever after both shots, 102 degrees fahrenheit at first dose, and 101fahrenheit after second dose), CHILLS (I had chills), MYALGIA (muscle ache) and VACCINATION SITE PAIN (pain at injection site). At the time of the report, MENSTRUAL DISORDER (I have been having two weeks of persistent abnormal bleeding, This abnormal bleeding began September 14, stopped after 3 days then began again), MENSTRUATION DELAYED (I skipped a cycle in August) and INTERMENSTRUAL BLEEDING (Clotty kind of blood, which is abnormal than my regular period) had not resolved and PRURITUS (itchiness), PYREXIA (I had fever after both shots, 102 degrees fahrenheit at first dose, and 101fahrenheit after second dose), CHILLS (I had chills), MYALGIA (muscle ache) and VACCINATION SITE PAIN (pain at injection site) outcome was unknown. No concomitant product was reported. Treatment information was not provided. This case was linked to MOD-2021-351211 (Patient Link).

Other Meds:

Current Illness:

ID: 1800518
Sex: F
Age: 67
State: GA

Vax Date: 09/16/2021
Onset Date: 09/16/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). On 16-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. The vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration. The vials did not undergo any temperature excursions.

Other Meds:

Current Illness:

ID: 1800519
Sex: M
Age: 69
State: GA

Vax Date: 09/16/2021
Onset Date: 09/16/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications reported. No treatment reported.

Other Meds:

Current Illness:

ID: 1800520
Sex: M
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Reporter stated that, It was unknown if the doses were first, second or third doses for the patients. 10 patients were administered the dose on 09Sep2021, 20 patients on 16Sep2021, 11 patients on 30Sep2021, 9 patients on 07Oct2021, 10 patients on 08Oct2021 and 20 patients on 11Oct2021. No concomitant medications were reported. No treatment medications were provided.

Other Meds:

Current Illness:

ID: 1800521
Sex: F
Age: 67
State: GA

Vax Date: 09/30/2021
Onset Date: 09/30/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 30-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). On 30-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported No treatment medications were reported

Other Meds:

Current Illness:

ID: 1800522
Sex: M
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant use were reported No Treatment were reported

Other Meds:

Current Illness:

ID: 1800523
Sex: M
Age: 78
State: GA

Vax Date: 09/30/2021
Onset Date: 09/30/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 30-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). On 30-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment and concomitant information was provided.

Other Meds:

Current Illness:

ID: 1800524
Sex: M
Age: 74
State: GA

Vax Date: 09/30/2021
Onset Date: 09/30/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 30-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). On 30-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that the vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration and the vials did not undergo any temperature excursions. No concomitant drug information was provided.

Other Meds:

Current Illness:

ID: 1800525
Sex: F
Age: 85
State: GA

Vax Date: 09/30/2021
Onset Date: 09/30/2021
Rec V Date: 10/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 30-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). On 30-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided. No treatment medication was provided.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am